Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Merck
Moodys
Harvard Business School
Mallinckrodt

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

Polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous and what is the scope of patent protection?

Polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous is the generic ingredient in twelve branded drugs marketed by Mylan Speciality Lp, Braintree, Mylan, Novel Labs Inc, Paddock Llc, Strides Pharma, Vintage Pharms, Dynapharm, E Z Em, Goldline, and Sandoz, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

There are four hundred and twenty-one drug master file entries for polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous. Seven suppliers are listed for this compound.

Summary for polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous
Recent Clinical Trials for polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Temple UniversityPhase 4

See all polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous clinical trials

Pharmacology for polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous

US Patents and Regulatory Information for polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Speciality Lp COLYTE polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous FOR SOLUTION;ORAL 018983-006 Oct 26, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Strides Pharma POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous FOR SOLUTION;ORAL 204558-001 Dec 21, 2018 AA RX No No   Start Trial   Start Trial   Start Trial
Mylan Speciality Lp COLYTE polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous FOR SOLUTION;ORAL 018983-010 Jan 31, 1989 DISCN No No   Start Trial   Start Trial   Start Trial
Vintage Pharms GO-EVAC polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous FOR SUSPENSION;ORAL 073433-001 Apr 28, 1992 DISCN No No   Start Trial   Start Trial   Start Trial
Dynapharm COLOVAGE polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous FOR SUSPENSION;ORAL 071320-001 Apr 20, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
Vintage Pharms CO-LAV polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous FOR SUSPENSION;ORAL 073428-001 Jan 28, 1992 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
AstraZeneca
Johnson and Johnson
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.